Internal Medicine, Endocrinology, Diabetes, & Metabolism · Miami, FL
NPI
1578621702
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5040 NW 7th St, Ste 635
Miami, FL, 33126
Phone (305) 644-2212
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
853 services
Medicare patients, 2024
268
Average age 76
Drug cost, 2024
$23.6M
59,657 prescriptions
Company payments, 2025
$110K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eugenio Angueira-Serrano was code 99214 (office e&m - established), 348 times for 155 patients. In total Eugenio Angueira-Serrano billed 853 services in 26 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 348 | 155 | $105.42 | $37K |
| 99310 SNF E&M | Facility | 107 | 38 | $123.47 | $13K |
| 99204 Office E&M - New | Office | 61 | 61 | $141.48 | $8,631 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 54 | 36 | $13.67 | $738 |
| 99213 Office E&M - Established | Office | 51 | 41 | $72.49 | $3,697 |
| 95251 Test - Miscellaneous | Office | 45 | 23 | $28.51 | $1,283 |
| 99232 Hospital E&M - Subsequent | Facility | 39 | 18 | $66.18 | $2,581 |
| 76536 Ultrasound - Nonspecific | Office | 27 | 24 | $89.64 | $2,420 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $145.07 | $1,596 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $110.83 | $1,219 |
By year: 2022 $68K for 691 services; 2023 $62K for 625 services; 2024 $82K for 853 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eugenio Angueira-Serrano prescribed most often to Medicare patients was Ozempic (Semaglutide), with 5,444 prescriptions and refills. In total Eugenio Angueira-Serrano wrote 59,657 Medicare prescriptions that cost $23.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 5,444 | 6,188 | 885 | $5.8M |
| Repaglinide Generic | 3,196 | 5,319 | 744 | $58K |
| Jardiance Empagliflozin | 3,055 | 4,374 | 671 | $2.6M |
| Atorvastatin Calcium Generic | 2,928 | 7,212 | 1,038 | $20K |
| Rosuvastatin Calcium Generic | 2,801 | 6,462 | 901 | $23K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 2,328 | 3,911 | 670 | $11K |
| Mounjaro Tirzepatide | 1,949 | 2,035 | 293 | $2.1M |
| Trulicity Dulaglutide | 1,812 | 1,988 | 365 | $1.9M |
| Synthroid Levothyroxine Sodium | 1,780 | 3,689 | 419 | $161K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 1,586 | 2,511 | 391 | $167K |
| Ezetimibe Generic | 1,561 | 3,377 | 460 | $14K |
| Metformin Hcl Generic | 1,538 | 3,427 | 537 | $6,440 |
| Levothyroxine Sodium Generic | 1,438 | 3,359 | 512 | $13K |
| Pioglitazone Hcl Generic | 1,401 | 3,187 | 441 | $11K |
| Tresiba Flextouch U-100 Insulin Degludec | 1,228 | 1,979 | 281 | $626K |
Brand drugs: 30,660 claims; generic drugs: 24,916 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eugenio Angueira-Serrano $110K ($110K in general payments such as food, travel and fees) from 33 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 49 | $20K |
| Novo Nordisk Inc NVO | 32 | $19K |
| Recordati_rare_diseases_inc. | 28 | $18K |
| Corcept Therapeutics CORT | 34 | $17K |
| Ascendis Pharma Endocrinology Inc ASND | 14 | $9,512 |
| Lilly USA, LLC LLY | 24 | $6,826 |
| Chiesi USA, Inc. | 6 | $6,337 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $5,650 |
| Madrigal Pharmaceuticals MDGL | 6 | $2,876 |
| CeQur Corporation | 2 | $2,040 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.